Understanding the Class Action for Applied Therapeutics Investors
As an investor in Applied Therapeutics, Inc. (APLT), you may have felt the financial impact of recent challenges the company has encountered. The firm is currently facing a class action lawsuit aimed at addressing securities fraud that adversely affected investors between specific dates. This situation is critical for shareholders who wish to seek reimbursement for their losses and understand their rights as members of this class.
What Led to the Class Action Lawsuit?
The crux of the lawsuit arose from a significant event in the company's journey. On a specific date, Applied Therapeutics announced that it had received a Complete Response Letter (CRL) from the FDA regarding its New Drug Application (NDA) for their lead drug candidate, govorestat. This CRL indicated that the FDA was unable to approve the NDA in its current form, citing clinical application deficiencies. Consequently, this announcement triggered a substantial drop in the company's stock price, raising concerns among investors.
The Impact on Stock Prices
Following the CRL announcement, Applied Therapeutics saw its stock price plummet dramatically from $10.21 to $8.57 the next day. Further declines followed, with shares dropping to $2.03 and $1.75 in the days that followed. By the time the situation escalated with an additional FDA warning letter linked to clinical trial issues, the share price continued to dwindle, resulting in a staggering total decline of over 80% within a few days. These events highlight the volatility and risks involved, thus prompting the class action.
Eligibility for Participation in the Class Action
If you are an investor who experienced losses during this tumultuous period, you have the opportunity to participate in this class action. The lawsuit is intended for shareholders affected from the beginning of January until early December. One important aspect to note is that engaging in this lawsuit does not necessitate serving as a lead plaintiff; every class member has the right to recover without taking on this role.
No Financial Burden on Class Members
One appealing feature of the class action is that it offers a no-cost participation model. As a class member, you may receive compensation without incurring any out-of-pocket expenses. The accessibility of this legal action emphasizes the importance of safeguarding investor rights without additional financial strain.
Next Steps for Affected Investors
Why Choose Levi & Korsinsky?
Levi & Korsinsky has established a strong reputation over the past 20 years, recovering substantial amounts for their clients. Their experience in representing investors in complex securities litigation makes them a qualified choice for those affected by the Applied Therapeutics situation. With a sizable team dedicated to client interests, they offer extensive resources for navigating the legal landscape.
Contact Information for Class Members
If you want to learn more about the class action or have inquiries regarding your eligibility, you can reach out to Levi & Korsinsky directly. Joseph E. Levi, Esq. can be contacted via email or by telephone to discuss your situation further. The firm’s commitment to supporting their clients is evident in their accessibility, making it easier for affected investors to seek guidance.
Frequently Asked Questions
What does the class action seek to achieve?
The class action aims to recover losses for shareholders affected by the alleged securities fraud of Applied Therapeutics.
How can I join the class action?
You can participate by expressing your interest before the deadline and ensuring you meet the eligibility criteria set forth in the lawsuit.
What costs are associated with joining?
There are no out-of-pocket costs for class members, allowing you to recover potential losses without financial burden.
What is Levi & Korsinsky's experience?
Levi & Korsinsky has a long track record of securing favorable outcomes for shareholders and is regarded as one of America’s leading securities litigation firms.
How will I be notified if there are updates?
Once you join the class, you'll receive updates directly regarding the progress of the case and any relevant legal developments.
